Assoc. Prof. Ooi Joshua Ooi (PhD, 2009) is an Australian NHMRC Leadership Fellow and Head of the Treg Therapies Group at Monash University. The vision of his group is to translate their high-profile experimental work on regulatory T cells (Tregs) into clinical treatments for patients with autoimmune diseases. He has published his work in the high-impact journals PNAS 2012, JCI 2013 and Nat Commun 2019; as well as >20 times in the top two nephrology journals JASN and Kidney Int. Importantly, he published a landmark paper in Nature, 2017, showing that antigen-specific Tregs were key protectors of autoimmune disease. He has received numerous prestigious prizes for these works including the international Mosaic of Autoimmunity Award, Best Science Awards from both the Australian Immunology and Nephrology societies, and the Victoria Prize for Science and Innovation.